google-site-verification: googlec7193c3de77668c9.html

Semaglutide may improve motivation with major depressive disorder

[

Semaglutide may improve motivation with major depressive disorder

Treatment with semaglutide significantly improves measures of motivation in patients with major depressive disorder (MDD), according to a study published April 29 in JAMA Psychiatry.

Hartej Gill, Ph.D., from University of Toronto, and colleagues assessed the effects of semaglutide, on reward-related dysfunction in a population with MDD. The analysis included 72 participants with a diagnosis of MDD and a body mass index ≥25 kg/m2 who were randomly assigned to oral semaglutide (35 individuals) or placebo (37 individuals).

The researchers found that semaglutide-treated participants showed a pattern of increased willingness to exert physical efforts with higher expected values of reward (treatment × visit × expected value interaction: χ2 = 12.024). Semaglutide’s effects on choice behavior were a result of reduced effort discounting, according to computational modeling. Semaglutide was associated with a significant reduction in sensitivity (β = −1.737), while there was no treatment effect on sensitivity to probability (β = −0.776).

“Semaglutide reduced the perceived cost of effort, relative to the monetary reward; the results of this trial have implications for the treatment of multiple neuropsychiatric disorders, which are characterized by varied reward dysfunctions,” the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Publication details

Hartej Gill et al, Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder, JAMA Psychiatry (2026). DOI: 10.1001/jamapsychiatry.2026.0594

Journal information:
JAMA Psychiatry


Who’s behind this story?


Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news.

Full profile →

Advertisements

Andrew Zinin

Andrew Zinin

Master’s in physics with research experience. Long-time science news enthusiast. Plays key role in Science X’s editorial success.

Full profile →

© 2026 HealthDay. All rights reserved.

Citation:
Semaglutide may improve motivation with major depressive disorder (2026, May 13)
retrieved 13 May 2026
from https://medicalxpress.com/news/2026-05-semaglutide-major-depressive-disorder.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

Views: 0

See also  Mimicking exercise with a pill

Check Also

Scientists solve the neurological mystery of ‘hyperfamiliar’ faces

[ The York team used neuroimaging to monitor Jenny’s brain activity while she watched clips …

How do weight-loss drugs like Mounjaro and Wegovy work?

Wegovy and Mounjaro are available to certain patients on the NHS, and can also be …

Ted Turner’s brain disease more common than previously thought, review finds

[ The degenerative brain disease that claimed CNN founder Ted Turner’s life is likely more …

Leave a Reply

Available for Amazon Prime
Link. Resmi cassinox giriş portalını.